FDA Inspection 1267929 — Rubicon Research Private Ltd
The FDA completed an inspection of Rubicon Research Private Ltd on Mar 20, 2025 in Thane. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Thane (India)